5 results
10-K
2021 FY
DAWN
Day One Biopharmaceuticals, Inc.
7 Mar 22
Annual report
7:36am
to the expected term of the stock option grants. The comparable companies are chosen based on their size, stage in the life cycle or area of specialty … are chosen based on their size, stage in the life cycle or area of specialty. The Company will continue to apply this process until sufficient historical
10-Q
2021 Q2
DAWN
Day One Biopharmaceuticals, Inc.
10 Aug 21
Quarterly report
5:26pm
on their size, stage in the life cycle or area of specialty. The Company will continue to apply this process until sufficient historical information regarding
- Prev
- 1
- Next